A new trading day began on Friday, with Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) stock price down -7.73% from the previous day of trading, before settling in for the closing price of $8.02. CRBP’s price has ranged from $4.64 to $61.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 35.71% over the last five years. Meanwhile, its annual earnings per share averaged -54.26%. With a float of $10.70 million, this company’s outstanding shares have now reached $12.23 million.
The firm has a total of 28 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Corbus Pharmaceuticals Holdings Inc (CRBP) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Corbus Pharmaceuticals Holdings Inc is 12.59%, while institutional ownership is 82.59%. The most recent insider transaction that took place on May 30 ’25, was worth 20,465. In this transaction Director of this company sold 2,783 shares at a rate of $7.35, taking the stock ownership to the 33 shares. Before that another transaction happened on May 30 ’25, when Company’s Director sold 1,392 for $7.25, making the entire transaction worth $10,096. This insider now owns 1,391 shares in total.
Corbus Pharmaceuticals Holdings Inc (CRBP) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -54.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.66% during the next five years compared to 35.71% growth over the previous five years of trading.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) Trading Performance Indicators
Here are Corbus Pharmaceuticals Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.23, a number that is poised to hit -1.50 in the next quarter and is forecasted to reach -4.49 in one year’s time.
Technical Analysis of Corbus Pharmaceuticals Holdings Inc (CRBP)
Analysing the last 5-days average volume posted by the [Corbus Pharmaceuticals Holdings Inc, CRBP], we can find that recorded value of 0.41 million was better than the volume posted last year of 0.2 million. As of the previous 9 days, the stock’s Stochastic %D was 34.59%.
During the past 100 days, Corbus Pharmaceuticals Holdings Inc’s (CRBP) raw stochastic average was set at 39.77%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.29% in the past 14 days, which was lower than the 85.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.67, while its 200-day Moving Average is $13.05. Now, the first resistance to watch is $7.83. This is followed by the second major resistance level at $8.27. The third major resistance level sits at $8.48. If the price goes on to break the first support level at $7.18, it is likely to go to the next support level at $6.97. Now, if the price goes above the second support level, the third support stands at $6.53.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) Key Stats
With a market capitalization of 90.55 million, the company has a total of 12,237K Shares Outstanding. Currently, annual sales are 0 K while annual income is -40,210 K. The company’s previous quarter sales were 0 K while its latest quarter income was -16,980 K.
